{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:36:52Z","timestamp":1791088612989,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.jinf.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T15:11:58Z","timestamp":1185894718000},"page":"254-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli"],"prefix":"10.1016","volume":"55","author":[{"given":"Mark","family":"Melzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6\u20137","key":"10.1016\/j.jinf.2007.04.007_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijmm.2005.07.007","article-title":"Virulence factors of septicaemic E. coli strains","volume":"295","author":"Mokady","year":"2005","journal-title":"Int J Med Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2007.04.007_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinids\/12.6.1008","article-title":"Bacteraemia due to E. coli: a study of 861 episodes","volume":"12","author":"Gransden","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkh424","article-title":"Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK","volume":"54","author":"Woodford","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2007.04.007_bib4","unstructured":"Health Protection Agency. Pearson A, Livermore D, McCloskey B, Duckworth G. Investigations into multi-drug resistant ESBL-producing Escherichia coli strains causing infections in England. Available from: <http:\/\/www.hpa.org.uk\/publications\/2005\/esbl_report_05\/default.htm>."},{"key":"10.1016\/j.jinf.2007.04.007_bib5","unstructured":"Health Protection Agency, Livermoore D, Pillay D, Cane P. Antimicrobial resistance. Inevitable but not unmanageable. Available from: <http:\/\/www.hpa.org.uk\/publications\/PublicationDisplay.asp?PublicationID=25>."},{"issue":"4","key":"10.1016\/j.jinf.2007.04.007_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jinf.2007.04.007_bib7","unstructured":"Health Protection Agency. Laboratory detection and reporting of bacteria with extended spectrum beta-lactamases; 2006 [National standard method QSOP 51 issue 2.]. Available from: <http:\/\/www.hpa-standardmethods.org.uk\/pdf sops.asp>."},{"issue":"7","key":"10.1016\/j.jinf.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/432940","article-title":"Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy","volume":"41","author":"Lautenbach","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2007.04.007_bib9","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1086\/500663","article-title":"Extended-spectrum beta-lactamases and clinical outcomes: current data","volume":"42","author":"Ramphal","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/00365540210147516","article-title":"Bacteraemia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case control study of risk factors and outcomes","volume":"34","author":"Ho","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.50.4.1257-1262.2006","article-title":"Clinical and economic impact of bacteraemia with expended-spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"50","author":"Schwaber","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.04.007_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1542\/peds.2004-1289","article-title":"Risk factors for and outcomes of bloodstream infections caused by\u00a0extended-spectrum-beta-lactamase producing Escherichia coli and Klebsiella species in children","volume":"115","author":"Zaoutis","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2007.04.007_bib13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2007.04.007_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JCM.43.2.745-749.2005","article-title":"High rate of fatal cases of paediatric septicaemia caused by gram negative bacteraemia with extended-spectrum beta-lactamases in dar es salaam, Tanzania","volume":"43","author":"Blomberg","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.jinf.2007.04.007_bib15","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcomes with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.04.007_bib16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","article-title":"Extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome","volume":"28","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jinf.2007.04.007_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s15010-006-4114-z","article-title":"Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae","volume":"34","author":"Henshke-Bar-Meir","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2007.04.007_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2006.05.010","article-title":"Epidemiology of infections caused by extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp.: a nested case\u2013control study from a tertiary hospital in London","volume":"64","author":"Skippen","year":"2006","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.jinf.2007.04.007_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijantimicag.2005.06.012","article-title":"Clinical outcomes and therapeutic options of bloodstream infections caused by ESBL producing E. coli","volume":"26","author":"Meton","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jinf.2007.04.007_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteraemia due to\u00a0the CTX-M-type extended-spectrum beta-lactamase producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2007.04.007_bib21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteraemia due to extended-spectrum beta-lactamase producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.04.007_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary\u00a0tract infections due to E. coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.04.007_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jac\/dkg114","article-title":"Variable susceptibility to piperacillin\/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases","volume":"51","author":"Babini","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.04.007_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000007147","article-title":"Comparative activity of piperacillin\/tazobactam against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"44","author":"Pagani","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2007.04.007_bib25","series-title":"Essential medical statistics","author":"Kirkwood","year":"2003"},{"issue":"8521\u201322","key":"10.1016\/j.jinf.2007.04.007_bib26","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0140-6736(86)92756-X","article-title":"Community outbreak of multiresistant invasive Escherichia coli infection","volume":"2","author":"Eykyn","year":"1986","journal-title":"Lancet"},{"issue":"8593","key":"10.1016\/j.jinf.2007.04.007_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(88)91853-3","article-title":"Epidemic multiresistant Escherichia coli infection in West Lambeth health district","volume":"1","author":"Phillips","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jinf.2007.04.007_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3201\/eid1101.040257","article-title":"Genetic background of Escherichia coli and extended-spectrum beta-lactamase type","volume":"11","author":"Branger","year":"2005","journal-title":"Emerging Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2007.04.007_bib29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1469-0691.2006.01536.x","article-title":"Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases","volume":"12","author":"Lavigne","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jinf.2007.04.007_bib30","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1128\/AAC.49.11.4667-4670.2005","article-title":"Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases","volume":"49","author":"Pitout","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2007.04.007_bib31","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1086\/500663","article-title":"Extended-spectrum beta-lactamase and clinical outcomes: current data","volume":"42","author":"Ramphal","year":"2006","journal-title":"Clin Infec Dis"},{"issue":"1","key":"10.1016\/j.jinf.2007.04.007_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosomycin in the treatment of extended spectrum beta-lactamase producing Escherichia coli related lower urinary tract infections","volume":"29","author":"Pulluku","year":"2007","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:32:22Z","timestamp":1758987142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445307001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0163445307001004"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2007.04.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2007.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}